DE69425149T2 - Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen - Google Patents

Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen

Info

Publication number
DE69425149T2
DE69425149T2 DE69425149T DE69425149T DE69425149T2 DE 69425149 T2 DE69425149 T2 DE 69425149T2 DE 69425149 T DE69425149 T DE 69425149T DE 69425149 T DE69425149 T DE 69425149T DE 69425149 T2 DE69425149 T2 DE 69425149T2
Authority
DE
Germany
Prior art keywords
pct
proteins
inhibitors
production
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69425149T
Other languages
English (en)
Other versions
DE69425149D1 (de
Inventor
Bengt Guss
Hans Jonsson
Matin Linberg
Hans-Peter Mueller
Liisa K Rantamaeki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69425149D1 publication Critical patent/DE69425149D1/de
Application granted granted Critical
Publication of DE69425149T2 publication Critical patent/DE69425149T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DE69425149T 1993-09-06 1994-09-06 Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen Expired - Fee Related DE69425149T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9302855A SE9302855D0 (sv) 1993-09-06 1993-09-06 Method and means for producing plasmaproteinase inhibitor binding proteins
PCT/SE1994/000826 WO1995007296A1 (en) 1993-09-06 1994-09-06 Method and means for producing plasmaproteinase inhibitor-binding proteins

Publications (2)

Publication Number Publication Date
DE69425149D1 DE69425149D1 (de) 2000-08-10
DE69425149T2 true DE69425149T2 (de) 2001-03-15

Family

ID=20390977

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69425149T Expired - Fee Related DE69425149T2 (de) 1993-09-06 1994-09-06 Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen

Country Status (9)

Country Link
US (1) US6100055A (de)
EP (1) EP0724596B1 (de)
AT (1) ATE194360T1 (de)
AU (1) AU7628194A (de)
CA (1) CA2176230A1 (de)
DE (1) DE69425149T2 (de)
ES (1) ES2149884T3 (de)
SE (1) SE9302855D0 (de)
WO (1) WO1995007296A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9823975D0 (en) * 1998-11-02 1998-12-30 Actinova Ltd Protein
DE60127401T2 (de) * 2000-06-12 2008-01-03 University Of Saskatchewan, Saskatoon Milchvieh immunisierung mit mig protein
RU2294366C2 (ru) * 2000-09-25 2007-02-27 Сосьете Де Продюи Нестле С.А. Трансформированные молочно-кислые бактерии, снижающие склонность к проявлению аллергических реакций, и их применение
CA2501621C (en) 2002-10-11 2012-01-24 Bengt Guss Immunization of non-human mammals against streptococcus equi
JP2011506433A (ja) 2007-12-13 2011-03-03 インターバック アーベー 改変された免疫組成物
CA2799136A1 (en) 2010-05-26 2011-12-01 Intervacc Ab Vaccine against streptococcal infections based on recombinant proteins
WO2018180205A1 (ja) * 2017-03-31 2018-10-04 株式会社カネカ 免疫グロブリン精製用アフィニティー分離マトリックス
RU2758604C2 (ru) * 2019-12-10 2021-11-01 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Рекомбинантный белок GM, обладающий способностью связывать α2-макроглобулин и его применение в качестве лиганда в аффинной хроматографии для выделения α2-макроглобулина из сыворотки крови человека

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins

Also Published As

Publication number Publication date
WO1995007296A1 (en) 1995-03-16
AU7628194A (en) 1995-03-27
ES2149884T3 (es) 2000-11-16
US6100055A (en) 2000-08-08
ATE194360T1 (de) 2000-07-15
DE69425149D1 (de) 2000-08-10
EP0724596A1 (de) 1996-08-07
SE9302855D0 (sv) 1993-09-06
CA2176230A1 (en) 1995-03-16
EP0724596B1 (de) 2000-07-05

Similar Documents

Publication Publication Date Title
ATE224713T1 (de) Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression
ATE194593T1 (de) 3-(3,4-dioxyphenyl)-pyrrolidine als inhibitonen der typ iv - phosphodiesterase zur behandlung von entzündungskrankheiten
DE69432581D1 (de) Gewebeinhibitor für Metalloproteasen Type 3 (TIMP-3)
FI965031A (fi) Sieni, jossa AreA-geeni on muunnettu, ja Aspergillus oryzaesta peräisin oleva areA-geeni
DE69517331T2 (de) Verfahren und verbindungen zum screening von presynaptischen calcium kanal inhibitoren
DE69735364D1 (de) Modulatoren für die regenerierung von gewebe
ATE215062T1 (de) Verfahren zur herstellung von cyclohexen- carboxylatderivate
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
ES2193144T3 (es) Compuestos de dna que comprenden secuencias que codifican manuronano c-5-epimerasa.
ES2053907T3 (es) Pomada topica.
AU4279996A (en) New method for identifying and evaluating biologically active molecules
DE69425149D1 (de) Verfahren und mittel für die herstellung von bindungsproteinen für inhibitoren von plasmaproteinasen
DE59503269D1 (de) Verfahren zur bearbeitung von nukleinsäuren
DE69808475D1 (de) Aminosäurederivate zur behandlung von schlaganfall
ATE266719T1 (de) Verfahren und zusammensetzung zur herstellung von austrocknungstoleranten sporen von paecitomyces fumosoroseus
DE59402209D1 (de) Verfahren zum dreiseitigen Beschneiden von Stapeln aus Buchblocks, Broschüren o. dgl. und Schneidemaschine zum Durchführen des Verfahrens
DE69434072D1 (de) Regulierende nukleinsaeuresequenzen und verwendungen
DE69739263D1 (de) Produktion von proteinen, dafür kodierende plasmide und organismen, die solche plasmide enthalten
HU9303318D0 (en) New 2-saccharinyl-methyl-phosphates, and phosphinates, their use as proteolytic enzime inhibitors, process for producing them, and preparations containing them
ATE192437T1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4- alkyl- bzw. 4-cycloalkyl-pyridine
EP1416048A4 (de) An der bildung einer in exon 5 defekten spleissvariante des presenilin-2-gens beteiligte nukleinsäure
DE59611353D1 (de) Transketolase-verwandtes protein
ATE301625T1 (de) Verfahren zur herstellung von 2,6- dimethylnaphthalin
ATE175668T1 (de) Verfahren zur herstellung von 8-g(a),12-oxido- 13,14,15,16-tetranorlabdan
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee